Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
GRAS Notice Inventory
FDA Home
GRAS Notice Inventory
GRAS Notice Inventory
GRAS Detail
-
Your browser settings indicate that JavaScript is currently disabled. Some features on this page may require the use of JavaScript. You may need to enable JavaScript in order to enjoy the full functionality of this page.
GRN No. 274
Novozymes North America, Inc.
77 Perry Chapel Church Rd.
Box 576
Franklinton, NC 27525
Return to Listing
Substance:
Branching glycosyltransferase enzyme preparation from
Bacillus subtilis
expressing a branching glycosyltransferase gene from
Rhodothermus obamensis
Intended Use:
As an enzyme in the starch industry to obtain dextrins with improved physical properties, such as higher solubility, lower viscosity, and reduced retrogradation
Basis:
Scientific procedures
Date of filing:
30-DEC-08
Date of closure (select to view letter):
25-JUN-09
GRAS Notice (disclosable information):
GRN 274
-
-